AUD 0.04
(-5.26%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | -5.83 Million AUD | -161.0% |
2023 | 9.57 Million AUD | -9.36% |
2022 | 10.56 Million AUD | 100.46% |
2021 | 5.26 Million AUD | 30.06% |
2020 | 4.05 Million AUD | -0.31% |
2019 | 4.06 Million AUD | 121.1% |
2018 | 1.83 Million AUD | 58.14% |
2017 | 1.16 Million AUD | -25.64% |
2016 | 1.56 Million AUD | 144.74% |
2015 | 638.67 Thousand AUD | 18.64% |
2014 | 538.31 Thousand AUD | 159.78% |
2013 | 207.22 Thousand AUD | -12.16% |
2012 | 235.91 Thousand AUD | -89.41% |
2011 | 2.22 Million AUD | 0.0% |
2010 | - AUD | 0.0% |
2009 | - AUD | 0.0% |
2008 | - AUD | -100.0% |
2007 | 374.56 Thousand AUD | 0.0% |
2006 | - AUD | 0.0% |
2005 | - AUD | 0.0% |
2004 | - AUD | -100.0% |
2003 | 19.00 AUD | -100.0% |
2002 | 1.11 Million AUD | 15754.57% |
2001 | 7044.00 AUD | 0.0% |
2000 | - AUD | 0.0% |
1999 | - AUD | 0.0% |
1998 | - AUD | -100.0% |
1997 | 3.85 Million AUD | 1288.13% |
1996 | 278 Thousand AUD | 47.87% |
1995 | 188 Thousand AUD | 0.0% |
1994 | - AUD | 0.0% |
1993 | - AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q4 | - AUD | 0.0% |
2024 FY | -5.83 Million AUD | -161.0% |
2024 Q2 | 8.06 Million AUD | 0.0% |
2023 FY | 9.57 Million AUD | -9.36% |
2023 Q4 | 6.96 Million AUD | 0.0% |
2023 Q2 | 4.81 Million AUD | 0.0% |
2022 Q4 | 7.62 Million AUD | 0.0% |
2022 FY | 10.56 Million AUD | 100.46% |
2022 Q2 | 5.34 Million AUD | 0.0% |
2021 FY | 5.26 Million AUD | 30.06% |
2021 Q2 | 4.08 Million AUD | 0.0% |
2021 Q4 | 3.14 Million AUD | 0.0% |
2020 Q2 | 2.37 Million AUD | 0.0% |
2020 FY | 4.05 Million AUD | -0.31% |
2020 Q4 | 1.75 Million AUD | 0.0% |
2019 Q2 | 1.62 Million AUD | 0.0% |
2019 FY | 4.06 Million AUD | 121.1% |
2019 Q4 | 2.46 Million AUD | 0.0% |
2018 Q2 | 698.35 Thousand AUD | 0.0% |
2018 FY | 1.83 Million AUD | 58.14% |
2018 Q4 | 1.14 Million AUD | 0.0% |
2017 Q2 | 769.09 Thousand AUD | 0.0% |
2017 FY | 1.16 Million AUD | -25.64% |
2017 Q4 | 394.95 Thousand AUD | 0.0% |
2016 FY | 1.56 Million AUD | 144.74% |
2016 Q4 | 927.91 Thousand AUD | 0.0% |
2016 Q2 | 636.35 Thousand AUD | 0.0% |
2015 Q2 | 482 Thousand AUD | 0.0% |
2015 FY | 638.67 Thousand AUD | 18.64% |
2015 Q4 | 156.67 Thousand AUD | 0.0% |
2014 Q2 | 6827.00 AUD | 0.0% |
2014 FY | 538.31 Thousand AUD | 159.78% |
2014 Q4 | 531.48 Thousand AUD | 0.0% |
2013 Q3 | - AUD | -100.0% |
2013 Q4 | 192.34 Thousand AUD | 0.0% |
2013 Q2 | 14.87 Thousand AUD | -74.79% |
2013 Q1 | 58.97 Thousand AUD | 0.0% |
2013 FY | 207.22 Thousand AUD | -12.16% |
2012 FY | 235.91 Thousand AUD | -89.41% |
2012 Q4 | 58.97 Thousand AUD | 0.0% |
2012 Q3 | 58.97 Thousand AUD | 0.0% |
2012 Q2 | 58.97 Thousand AUD | -89.41% |
2012 Q1 | 556.75 Thousand AUD | 0.0% |
2011 FY | 2.22 Million AUD | 0.0% |
2011 Q4 | 556.75 Thousand AUD | 0.0% |
2011 Q3 | 556.75 Thousand AUD | 0.0% |
2011 Q2 | 556.75 Thousand AUD | 0.0% |
2011 Q1 | - AUD | 0.0% |
2010 Q1 | - AUD | 0.0% |
2010 Q2 | - AUD | 0.0% |
2010 Q4 | - AUD | 0.0% |
2010 Q3 | - AUD | 0.0% |
2010 FY | - AUD | 0.0% |
2009 Q2 | - AUD | 0.0% |
2009 Q4 | - AUD | 0.0% |
2009 Q3 | - AUD | 0.0% |
2009 FY | - AUD | 0.0% |
2009 Q1 | - AUD | 0.0% |
2008 Q1 | 393.00 AUD | 0.0% |
2008 FY | - AUD | -100.0% |
2008 Q4 | - AUD | 0.0% |
2008 Q3 | - AUD | 0.0% |
2008 Q2 | - AUD | -100.0% |
2007 Q2 | 393.00 AUD | 0.0% |
2007 Q4 | 393.00 AUD | 0.0% |
2007 FY | 374.56 Thousand AUD | 0.0% |
2007 Q1 | - AUD | 0.0% |
2007 Q3 | 393.00 AUD | 0.0% |
2006 Q3 | - AUD | 0.0% |
2006 FY | - AUD | 0.0% |
2006 Q4 | - AUD | 0.0% |
2006 Q2 | - AUD | 0.0% |
2006 Q1 | - AUD | 0.0% |
2005 FY | - AUD | 0.0% |
2005 Q4 | - AUD | 0.0% |
2005 Q1 | - AUD | 0.0% |
2005 Q3 | - AUD | 0.0% |
2005 Q2 | - AUD | 0.0% |
2004 FY | - AUD | -100.0% |
2004 Q3 | - AUD | 0.0% |
2004 Q2 | - AUD | -100.0% |
2004 Q1 | 4.75 AUD | 0.0% |
2004 Q4 | - AUD | 0.0% |
2003 Q4 | 4.75 AUD | 0.0% |
2003 FY | 19.00 AUD | -100.0% |
2003 Q3 | 4.75 AUD | 0.0% |
2003 Q1 | 279.19 Thousand AUD | 0.0% |
2003 Q2 | 4.75 AUD | -100.0% |
2002 Q1 | 1761.00 AUD | 0.0% |
2002 Q3 | 279.19 Thousand AUD | 0.0% |
2002 FY | 1.11 Million AUD | 15754.57% |
2002 Q2 | 279.19 Thousand AUD | 15754.57% |
2002 Q4 | 279.19 Thousand AUD | 0.0% |
2001 Q1 | - AUD | 0.0% |
2001 Q3 | 1761.00 AUD | 0.0% |
2001 Q4 | 1761.00 AUD | 0.0% |
2001 FY | 7044.00 AUD | 0.0% |
2001 Q2 | 1761.00 AUD | 0.0% |
2000 Q2 | - AUD | 0.0% |
2000 Q4 | - AUD | 0.0% |
2000 Q3 | - AUD | 0.0% |
2000 FY | - AUD | 0.0% |
2000 Q1 | - AUD | 0.0% |
1999 Q4 | - AUD | 0.0% |
1999 Q2 | - AUD | 0.0% |
1999 Q3 | - AUD | 0.0% |
1999 Q1 | - AUD | 0.0% |
1999 FY | - AUD | 0.0% |
1998 Q2 | - AUD | -100.0% |
1998 Q3 | - AUD | 0.0% |
1998 Q1 | 964.75 Thousand AUD | 0.0% |
1998 Q4 | - AUD | 0.0% |
1998 FY | - AUD | -100.0% |
1997 Q3 | 964.75 Thousand AUD | 0.0% |
1997 FY | 3.85 Million AUD | 1288.13% |
1997 Q4 | 964.75 Thousand AUD | 0.0% |
1997 Q2 | 964.75 Thousand AUD | 1288.13% |
1997 Q1 | 69.5 Thousand AUD | 0.0% |
1996 Q4 | 69.5 Thousand AUD | 0.0% |
1996 Q3 | 69.5 Thousand AUD | 0.0% |
1996 FY | 278 Thousand AUD | 47.87% |
1996 Q2 | 69.5 Thousand AUD | 47.87% |
1996 Q1 | 47 Thousand AUD | 0.0% |
1995 FY | 188 Thousand AUD | 0.0% |
1995 Q1 | - AUD | 0.0% |
1995 Q2 | 47 Thousand AUD | 0.0% |
1995 Q3 | 47 Thousand AUD | 0.0% |
1995 Q4 | 47 Thousand AUD | 0.0% |
1994 Q4 | - AUD | 0.0% |
1994 Q2 | - AUD | 0.0% |
1994 Q3 | - AUD | 0.0% |
1994 FY | - AUD | 0.0% |
1994 Q1 | - AUD | 0.0% |
1993 Q4 | - AUD | 0.0% |
1993 FY | - AUD | 0.0% |
1993 Q2 | - AUD | 0.0% |
1993 Q3 | - AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
EZZ Life Science Holdings Limited | 50.94 Million AUD | 111.463% |
Anatara Lifesciences Ltd | -748.91 Thousand AUD | -679.78% |
Zelira Therapeutics Limited | 10.28 Thousand AUD | 56885.774% |
Biome Australia Limited | 7.66 Million AUD | 176.142% |
Patrys Limited | 1.39 Million AUD | 518.878% |
Orthocell Limited | 3.68 Million AUD | 258.329% |
Noxopharm Limited | -534.81 Thousand AUD | -991.946% |
PYC Therapeutics Limited | 22.05 Million AUD | 126.473% |
Chimeric Therapeutics Limited | 7.45 Million AUD | 178.348% |
Prescient Therapeutics Limited | 3.71 Million AUD | 257.308% |
Proteomics International Laboratories Limited | -1.12 Million AUD | -419.935% |
Cynata Therapeutics Limited | 2.31 Million AUD | 352.191% |
CSL Limited | 15.28 Billion AUD | 100.038% |
Arovella Therapeutics Limited | -25.97 Thousand AUD | -22379.114% |
Bio-Gene Technology Limited | -301.44 Thousand AUD | -1837.259% |
Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 107.478% |
Starpharma Holdings Limited | 7.65 Million AUD | 176.268% |
Nanollose Limited | -348.95 Thousand AUD | -1573.539% |
Memphasys Limited | 1606.00 AUD | 363726.961% |
Invex Therapeutics Ltd | 1.21 Million AUD | 581.734% |
NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | -6293.739% |
Amplia Therapeutics Limited | 4.01 Million AUD | 245.605% |
Botanix Pharmaceuticals Limited | -6.55 Million AUD | 10.863% |
Island Pharmaceuticals Limited | 1.25 Million AUD | 566.6% |
Race Oncology Limited | 1.38 Million AUD | 520.159% |
Nyrada Inc. | -5164.07 AUD | -112986.17% |
Telix Pharmaceuticals Limited | 308.5 Million AUD | 101.893% |
Dimerix Limited | 583.47 Thousand AUD | 1100.869% |
PharmAust Limited | -1641.00 AUD | -355771.359% |
Immutep Limited | 1.44 Million AUD | 504.449% |
Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 150.752% |
Alterity Therapeutics Limited | 3.8 Million AUD | 253.479% |
BTC Health Limited | 16.36 Thousand AUD | 35795.899% |
Acrux Limited | -1.28 Million AUD | -354.817% |
Neuren Pharmaceuticals Limited | 205.17 Million AUD | 102.846% |
Biotron Limited | -40.49 Thousand AUD | -14320.092% |
Tissue Repair Ltd | 150.51 Thousand AUD | 3980.015% |
AdAlta Limited | 1.5 Million AUD | 487.28% |
Radiopharm Theranostics Limited | -21.3 Million AUD | 72.593% |
Hexima Limited | - AUD | Infinity% |
AnteoTech Limited | 460.39 Thousand AUD | 1368.438% |
Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 10379.253% |
Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | -1492.246% |
Avecho Biotechnology Limited | -43.79 Thousand AUD | -13234.511% |
Actinogen Medical Limited | 9.93 Million AUD | 158.801% |
Immuron Limited | 3.33 Million AUD | 275.014% |
Argenica Therapeutics Limited | 2.59 Million AUD | 324.788% |